nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2A6—Progesterone—uterine cancer	0.282	0.283	CbGbCtD
Dexfenfluramine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.147	0.147	CbGbCtD
Dexfenfluramine—CYP2C19—Progesterone—uterine cancer	0.117	0.117	CbGbCtD
Dexfenfluramine—CYP1A2—Progesterone—uterine cancer	0.108	0.108	CbGbCtD
Dexfenfluramine—CYP2C9—Progesterone—uterine cancer	0.0971	0.0973	CbGbCtD
Dexfenfluramine—CYP2D6—Progesterone—uterine cancer	0.0888	0.089	CbGbCtD
Dexfenfluramine—CYP2E1—Etoposide—uterine cancer	0.0834	0.0835	CbGbCtD
Dexfenfluramine—CYP1A2—Etoposide—uterine cancer	0.0482	0.0483	CbGbCtD
Dexfenfluramine—CYP2D6—Doxorubicin—uterine cancer	0.0271	0.0272	CbGbCtD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.71e-06	0.00287	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	4.54e-06	0.00276	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—uterine cancer	4.51e-06	0.00275	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	4.47e-06	0.00273	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	4.35e-06	0.00265	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	4.35e-06	0.00265	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	4.28e-06	0.00261	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	4.23e-06	0.00257	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	4.22e-06	0.00257	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—PTEN—uterine cancer	4.07e-06	0.00248	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.03e-06	0.00245	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.94e-06	0.0024	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.91e-06	0.00238	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—EP300—uterine cancer	3.89e-06	0.00237	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.89e-06	0.00237	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.85e-06	0.00235	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.82e-06	0.00233	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.82e-06	0.00233	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—SRD5A2—uterine cancer	3.77e-06	0.0023	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NDUFB11—uterine cancer	3.77e-06	0.0023	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.74e-06	0.00228	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.74e-06	0.00228	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.62e-06	0.00221	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.58e-06	0.00218	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	3.45e-06	0.0021	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.41e-06	0.00208	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.41e-06	0.00208	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.34e-06	0.00203	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKR1B10—uterine cancer	3.31e-06	0.00202	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	3.29e-06	0.00201	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	3.08e-06	0.00187	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.98e-06	0.00182	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.98e-06	0.00182	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	2.96e-06	0.0018	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.91e-06	0.00177	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.91e-06	0.00177	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	2.79e-06	0.0017	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TP53—uterine cancer	2.78e-06	0.00169	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RNF43—uterine cancer	2.75e-06	0.00167	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.74e-06	0.00167	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.73e-06	0.00166	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—STAR—uterine cancer	2.73e-06	0.00166	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.73e-06	0.00166	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKR1B10—uterine cancer	2.67e-06	0.00163	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CCL2—uterine cancer	2.63e-06	0.0016	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—PIK3CA—uterine cancer	2.62e-06	0.00159	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.62e-06	0.00159	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	2.55e-06	0.00155	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—INHBA—uterine cancer	2.51e-06	0.00153	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.5e-06	0.00152	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	2.39e-06	0.00145	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	2.34e-06	0.00143	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.3e-06	0.0014	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.3e-06	0.0014	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKR1C1—uterine cancer	2.26e-06	0.00138	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.24e-06	0.00136	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RNF43—uterine cancer	2.22e-06	0.00135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.2e-06	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	2.17e-06	0.00132	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.16e-06	0.00131	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—STAR—uterine cancer	2.16e-06	0.00131	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—POLD1—uterine cancer	2.14e-06	0.0013	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.14e-06	0.0013	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CCL2—uterine cancer	2.12e-06	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.12e-06	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.12e-06	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.11e-06	0.00129	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—PIK3CA—uterine cancer	2.11e-06	0.00129	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.1e-06	0.00128	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.1e-06	0.00128	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CXCL8—uterine cancer	2.08e-06	0.00127	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	2.05e-06	0.00125	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.04e-06	0.00124	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—INHBA—uterine cancer	2.03e-06	0.00123	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKR1C1—uterine cancer	2e-06	0.00122	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.93e-06	0.00117	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	1.89e-06	0.00115	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKR1C1—uterine cancer	1.82e-06	0.00111	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.79e-06	0.00109	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.79e-06	0.00109	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—RRM2—uterine cancer	1.79e-06	0.00109	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	1.75e-06	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.74e-06	0.00106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKR1C3—uterine cancer	1.74e-06	0.00106	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—DCN—uterine cancer	1.73e-06	0.00106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PGR—uterine cancer	1.7e-06	0.00103	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—POLD1—uterine cancer	1.69e-06	0.00103	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CXCL8—uterine cancer	1.68e-06	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.66e-06	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—STAR—uterine cancer	1.66e-06	0.00101	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.65e-06	0.001	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.64e-06	0.001	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.63e-06	0.000995	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—YWHAE—uterine cancer	1.62e-06	0.000986	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.58e-06	0.000964	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FBXW7—uterine cancer	1.55e-06	0.000945	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.54e-06	0.00094	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—STAR—uterine cancer	1.53e-06	0.000932	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.53e-06	0.000932	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—STAR—uterine cancer	1.52e-06	0.000924	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.52e-06	0.000924	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.5e-06	0.000914	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—RRM2—uterine cancer	1.41e-06	0.00086	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKR1C3—uterine cancer	1.4e-06	0.000856	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—DCN—uterine cancer	1.37e-06	0.000835	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PGR—uterine cancer	1.37e-06	0.000834	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STK11—uterine cancer	1.36e-06	0.000826	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CCL2—uterine cancer	1.35e-06	0.000823	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—YWHAE—uterine cancer	1.31e-06	0.000796	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—POLD1—uterine cancer	1.31e-06	0.000796	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.3e-06	0.00079	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—STAR—uterine cancer	1.3e-06	0.00079	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.29e-06	0.000786	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.28e-06	0.000781	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SOCS3—uterine cancer	1.27e-06	0.000774	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FBXW7—uterine cancer	1.25e-06	0.000763	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.22e-06	0.000744	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.22e-06	0.000742	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN2B—uterine cancer	1.22e-06	0.000741	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—STK11—uterine cancer	1.2e-06	0.000732	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.2e-06	0.000732	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—POLD1—uterine cancer	1.2e-06	0.000732	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—POLD1—uterine cancer	1.19e-06	0.000725	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IGF1R—uterine cancer	1.18e-06	0.000719	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCL8—uterine cancer	1.18e-06	0.000716	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.12e-06	0.000684	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.11e-06	0.000678	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SMAD3—uterine cancer	1.11e-06	0.000676	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STK11—uterine cancer	1.09e-06	0.000667	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CCL2—uterine cancer	1.09e-06	0.000664	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—RRM2—uterine cancer	1.09e-06	0.000663	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL8—uterine cancer	1.07e-06	0.00065	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGFR2—uterine cancer	1.06e-06	0.000645	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—DCN—uterine cancer	1.06e-06	0.000644	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SOCS3—uterine cancer	1.02e-06	0.000624	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—POLD1—uterine cancer	1.02e-06	0.00062	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—RRM2—uterine cancer	1e-06	0.00061	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.96e-07	0.000607	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—RRM2—uterine cancer	9.93e-07	0.000605	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN2B—uterine cancer	9.81e-07	0.000598	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—DCN—uterine cancer	9.72e-07	0.000592	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—DCN—uterine cancer	9.64e-07	0.000587	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF1R—uterine cancer	9.53e-07	0.00058	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKR1C1—uterine cancer	9.52e-07	0.00058	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP19A1—uterine cancer	9.49e-07	0.000578	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—STK11—uterine cancer	9.49e-07	0.000578	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL8—uterine cancer	9.48e-07	0.000578	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKR1C3—uterine cancer	9.4e-07	0.000573	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP11A1—uterine cancer	9.16e-07	0.000558	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP11A1—uterine cancer	9.08e-07	0.000553	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ESR1—uterine cancer	9.06e-07	0.000552	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MTHFR—uterine cancer	9.03e-07	0.00055	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SMAD3—uterine cancer	8.96e-07	0.000546	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKR1C3—uterine cancer	8.65e-07	0.000527	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL8—uterine cancer	8.61e-07	0.000525	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKR1C3—uterine cancer	8.57e-07	0.000522	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—NRAS—uterine cancer	8.56e-07	0.000522	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGFR2—uterine cancer	8.54e-07	0.00052	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—RRM2—uterine cancer	8.48e-07	0.000517	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—DCN—uterine cancer	8.23e-07	0.000502	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—uterine cancer	7.98e-07	0.000486	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP11A1—uterine cancer	7.76e-07	0.000473	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CA—uterine cancer	7.46e-07	0.000454	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—uterine cancer	7.37e-07	0.000449	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKR1C3—uterine cancer	7.33e-07	0.000446	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—STK11—uterine cancer	7.32e-07	0.000446	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP19A1—uterine cancer	7.32e-07	0.000446	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—uterine cancer	7.31e-07	0.000445	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—uterine cancer	7.13e-07	0.000435	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—NRAS—uterine cancer	6.91e-07	0.000421	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.88e-07	0.000419	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CA—uterine cancer	6.77e-07	0.000413	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—STK11—uterine cancer	6.74e-07	0.00041	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.74e-07	0.00041	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP19A1—uterine cancer	6.68e-07	0.000407	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—STK11—uterine cancer	6.68e-07	0.000407	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB2—uterine cancer	6.65e-07	0.000405	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.56e-07	0.0004	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—uterine cancer	6.43e-07	0.000392	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—uterine cancer	6.31e-07	0.000384	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.27e-07	0.000382	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRAS—uterine cancer	6.27e-07	0.000382	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1B—uterine cancer	6.16e-07	0.000375	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—uterine cancer	6.09e-07	0.000371	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CA—uterine cancer	6.02e-07	0.000367	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.98e-07	0.000364	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—uterine cancer	5.95e-07	0.000362	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CTNNB1—uterine cancer	5.82e-07	0.000354	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—STK11—uterine cancer	5.71e-07	0.000348	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.71e-07	0.000348	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTEN—uterine cancer	5.67e-07	0.000345	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—uterine cancer	5.53e-07	0.000337	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—uterine cancer	5.5e-07	0.000335	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	5.46e-07	0.000333	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EP300—uterine cancer	5.41e-07	0.000329	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB2—uterine cancer	5.36e-07	0.000327	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.36e-07	0.000326	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—uterine cancer	5.12e-07	0.000312	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.11e-07	0.000311	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—uterine cancer	5.09e-07	0.00031	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—uterine cancer	5.06e-07	0.000308	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NRAS—uterine cancer	5.06e-07	0.000308	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRAS—uterine cancer	5.05e-07	0.000308	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTEN—uterine cancer	5.02e-07	0.000306	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—uterine cancer	5.02e-07	0.000306	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	4.97e-07	0.000303	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	4.91e-07	0.000299	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.85e-07	0.000296	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—EP300—uterine cancer	4.79e-07	0.000292	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	4.69e-07	0.000286	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTEN—uterine cancer	4.57e-07	0.000279	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.46e-07	0.000272	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.42e-07	0.000269	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EP300—uterine cancer	4.36e-07	0.000266	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—uterine cancer	4.35e-07	0.000265	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—uterine cancer	4.29e-07	0.000261	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	4.13e-07	0.000252	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NRAS—uterine cancer	4.08e-07	0.000249	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	4e-07	0.000244	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTEN—uterine cancer	3.97e-07	0.000242	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—uterine cancer	3.87e-07	0.000236	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—EP300—uterine cancer	3.79e-07	0.000231	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.78e-07	0.00023	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRAS—uterine cancer	3.7e-07	0.000225	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.54e-07	0.000216	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.51e-07	0.000214	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—uterine cancer	3.27e-07	0.000199	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.23e-07	0.000197	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—uterine cancer	3.12e-07	0.00019	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTEN—uterine cancer	3.06e-07	0.000187	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRAS—uterine cancer	2.99e-07	0.000182	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—EP300—uterine cancer	2.92e-07	0.000178	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—uterine cancer	2.89e-07	0.000176	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTEN—uterine cancer	2.82e-07	0.000172	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.8e-07	0.000171	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTEN—uterine cancer	2.79e-07	0.00017	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—EP300—uterine cancer	2.69e-07	0.000164	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—EP300—uterine cancer	2.66e-07	0.000162	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.64e-07	0.000161	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTEN—uterine cancer	2.39e-07	0.000145	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—uterine cancer	2.29e-07	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—EP300—uterine cancer	2.28e-07	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.16e-07	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.99e-07	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.97e-07	0.00012	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—uterine cancer	1.76e-07	0.000108	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.68e-07	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—uterine cancer	1.62e-07	9.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—uterine cancer	1.61e-07	9.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—uterine cancer	1.38e-07	8.38e-05	CbGpPWpGaD
